Luminex Corporation
418 articles with Luminex Corporation
-
Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.
-
As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.
-
Luminex Corporation Declares Second Quarter Cash Dividend - May 20, 2021
5/20/2021
Luminex Corporation announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021.
-
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
3/10/2021
Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an Emergency Use Authorization application to the U.S. Food and Drug Administration for the company's new multi-analyte respiratory panel combining Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target.
-
Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference
3/9/2021
Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, Chairman, CEO & President, and Harriss Currie, Senior Vice President and CFO, plan to participate at the 2021 Barclays Global Healthcare Conference on March 10, 2021 at 8:35 a.m. Eastern Time
-
Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2
3/4/2021
Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) that includes the SARS-CoV-2 virus for high-throughput respiratory testing.
-
Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel
2/19/2021
Luminex Corporation (NASDAQ: LMNX) today announced that it has received $11.3 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.
-
Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
2/8/2021
Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31, 2020 . All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP"). CURRENT FINANCIAL HIGHLIGHTS Record revenue for the fourth quarter of $111.4M , a 23%
-
Luminex Corporation Declares First Quarter Cash Dividend
2/8/2021
Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2021 of $0.10 per share of common stock payable on April 15 , 2021 to stockholders of record as of the close of business March 25, 2021 .
-
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021
1/27/2021
Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020 on Monday, February 8, 2021 .
-
Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
1/13/2021
As previously announced, Luminex Corporation (Nasdaq: LMNX) will present at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually today, January 13, 2021 at 3:30 p.m. Central Time
-
Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue
1/12/2021
Luminex Corporation announced 4th quarter 2020 revenue of approximately $111M, up approximately 23% over the 4th quarter of 2019 and full-year revenue of approximately $417M, up approximately 25% over the full year 2019.
-
Luminex Corporation Declares Fourth Quarter 2020 Cash Dividend
12/7/2020
On December 3, 2020, Luminex Corporation, announced that its board of directors approved a $0.01 increase in the quarterly dividend, to $0.10 per share of common stock, payable on January 14, 2021 to stockholders of record as of the close of business December 23, 2021.
-
Luminex Corporation Reports Strong Third Quarter 2020 Results
11/5/2020
Luminex Corporation announced results for its third quarter ended September 30, 2020.
-
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020
10/22/2020
Luminex Corporation announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020.
-
Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue
10/7/2020
Luminex Corporation announced 3rd quarter 2020 revenues of approximately $106 million, up approximately 35% over the 3rd quarter of 2019.
-
Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2
9/24/2020
Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary f
-
Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test
9/23/2020
Project will expand utility of xMAP SARS-CoV-2 Multi-Antigen IgG Assay to better indicate whether individuals are protected against future infection [23-September-2020] AUSTIN, Texas , Sept. 23, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development Autho
-
Luminex Corporation Declares Third Quarter 2020 Cash Dividend
9/15/2020
On September 10, 2020, Luminex Corporation, announced that its board of directors declared a cash dividend for the third quarter of 2020 of $0.09 per share of common stock payable on October 15, 2020 to stockholders of record as of the close of business September 24, 2020.
-
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors
8/4/2020
Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors ("Board") effective August 3, 2020.